Axitinib Impurity 47

Basic Information

View in Editor

CAS Number

20054-45-9

Molecular Formula

C8H9NOS

Molecular Weight

167.23 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Fine Chemicals Dyes and Pigments Organic Dyes

Basic Physical Properties

SMILES

View in Editor

CNC(=O)C1=CC=CC=C1S

InChI

InChI=1S/C8H9NOS/c1-9-8(10)6-4-2-3-5-7(6)11/h2-5,11H,1H3,(H,9,10)

InChIKey

VIFOAZNEQRHREM-UHFFFAOYSA-N

LogP

1.3349

Topological Polar Surface Area

29.1 Å²

Hydrogen Bond Donor/Acceptor

1 / 2

Complexity

149

Synonyms & References

English

DTXSID10403947
AS-75577
N-methylthiosalicylamide
Benzamide, 2-mercapto-N-methyl-
AC-26794
2-mercapto-N-methyl-Benzamide
FT-0690189
2-MERCAPTO-N-METHYLBENZAMIDE
VIFOAZNEQRHREM-UHFFFAOYSA-N
F12015
CS-0016511
SCHEMBL2829218
20054-45-9
AKOS000196042
N-methyl-2-sulfanylbenzamide
BCP11862
MFCD00136334
AM20090683
SY233328
3-(2-Bromoacetyl)-5-chloro-N-(2-methoxyethyl)thiophene-2-sulfonamide
NS00128719
Benzamide,2-mercapto-N-methyl-
2-Mercapto-N-methylbenzamide
2-Mercapto-N-methyl-benzamide
2- Mercapto-N-MethyllbenzaMide
2-mercapto-N-methylbenzamide

MDL Number

MFCD00136334

FAQ

What regulatory guidelines apply to Axitinib Impurity 47 (CAS: 20054-45-9)?

Axitinib Impurity 47 (CAS: 20054-45-9) is subject to regulatory guidelines such as the Globally Harmonized System of Classification and Labeling of Chemicals (GHS), REACH regulations in the European Union, and FDA/EPA requirements for pharmaceutical and chemical substances. Compliance with these guidelines ensures safety and proper handling in manufacturing and distribution.

Are there alternatives to Axitinib Impurity 47 (CAS: 20054-45-9) in synthesis?

In synthesis, alternatives to Axitinib Impurity 47 (CAS: 20054-45-9) include using isomers, analogs, and other substitute reagents. For instance, using isomers with similar properties or alternative impurities can provide a viable synthesis route. These alternatives should be carefully evaluated for their effectiveness and safety.

What is the market or research trend for Axitinib Impurity 47 (CAS: 20054-45-9)?

The market and research trend for Axitinib Impurity 47 (CAS: 20054-45-9) reflects increasing interest in pharmaceuticals and targeted therapy research. Trends indicate a focus on improving drug purity and reducing impurity levels, leading to advancements in purification techniques and analytical methods.

How should waste containing Axitinib Impurity 47 (CAS: 20054-45-9) be handled?

Waste containing Axitinib Impurity 47 (CAS: 20054-45-9) should be collected and disposed of in accordance with local environmental regulations. Proper waste handling includes incineration or professional waste disposal services. Ensure compliance with environmental protection measures to minimize ecological impact and ensure safety during disposal processes.